BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 26, 2006
View Archived Issues
Pentavalent human-bovine vaccine reduces rotavirus gastroenteritis
Read More
Suberoylanilide hydroxamic acid active in lymphoma patients
Read More
Synbiotics maintain gut environment in severe SIRS patients
Read More
Update on biomarkers in breast cancer
Read More
Toyama outlicenses Korean rights for T-3811 to Dong-A
Read More
Promising preclinical results in Duchenne muscular dystrophy at VASTox
Read More
GemVax and Ulleval University Hospital collaborate on translational research
Read More
New subcutaneous formulation of Genasense investigated
Read More
Migenix profiles pipeline progress
Read More
Clinical candidate selected from Array BioPharma and AstraZeneca collaboration
Read More
Eurand inlicenses novel analgesic compounds from Italian universities
Read More
Can-Fite BioPharma signs CRADA with NIH for A3 adenosine receptor agonists
Read More
Posiphen completes first phase I study for Alzheimer's disease progression
Read More
New phase I study investigates PR-104 to treat hypoxic tumors
Read More
Curis updates phase I basal cell carcinoma study
Read More
Pfizer updates Canadian safety information for Macugen
Read More
New pegylated wortmannin conjugates demonstrate antitumor activity
Read More
LAB CGRP, safe with no serious adverse events in phase I study
Read More
Japanese approval for Plavix
Read More
Approvable letter for Yaz
Read More
GW-3965 protects against endotoxic liver injury and dysfunction
Read More
Novel agents for treating endocrine-related disorders disclosed in recent patents
Read More
Recent Vertex patent reports new agents for cystic fibrosis
Read More
Antiarrhythmic agents emerge from AstraZeneca R&D
Read More
Erectile dysfunction medications may be associated with increased risk of optic nerve damage
Read More